Real-World effectiveness of eculizumab in atypical hemolytic uremic syndrome: a retrospective study from Western China
ObjectiveTo evaluate the real-world efficacy and safety of eculizumab in atypical hemolytic uremic syndrome (aHUS) within a Western Chinese cohort, with emphasis on treatment initiation timing and renal outcomes.MethodsWe conducted a retrospective analysis of 17 aHUS patients treated at Sichuan Prov...
Saved in:
| Main Authors: | Yun Hu, Yanyan Zhang, Wei Wang, Guisen Li, Shasha Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1568082/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SUCCESSFUL TREATMENT FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME IN A PUERPERA
by: O. N. Ulitkina, et al.
Published: (2016-01-01) -
ATYPICAL HEMOLYTIC-UREMIC SYNDROME IN THE FEMALE PATIENT WITH CONCURRENT MENOMETRORRHAGIA (clinical case)
by: A. V. Pyregov, et al.
Published: (2018-01-01) -
Treatment of atypical hemolytic uremic syndrome with eculizumab in a patient presenting with neuropsychiatric prodrome: a case report
by: Hanze Yang, et al.
Published: (2025-04-01) -
Difficulties in diagnosing atypical hemolytic uremic syndrome
by: N. V. Fomina, et al.
Published: (2020-01-01) -
Meningococcemia in a vaccinated child receiving eculizumab and review of the literature
by: Diana Üçkardeş, et al.
Published: (2023-02-01)